Drug intelligence / Profile preview

Zicam Cold & Flu Relief

Development stage
Unknown
Lead developer
RepHresh Pro-B
Modality
Small Molecules
Administration
Oral
01

Overview

Zicam Cold & Flu Relief is a homeopathic over-the-counter (OTC) product developed and distributed by Church & Dwight. It is formulated as quick-dissolve tablets containing a combination of active ingredients: zinc acetate, zinc gluconate, *Echinacea angustifolia*, and *Sambucus nigra* (elderberry). The product is marketed to temporarily relieve symptoms associated with the common cold and flu, including cough, sore throat, chest congestion, hoarseness, body aches, fever, and chills. While the zinc components are traditionally intended to reduce the duration of the common cold, the herbal components are included based on homeopathic practices. It is important to note that these claims are based on traditional homeopathic practice and are not supported by accepted medical evidence; the product has not been evaluated by the FDA for safety or efficacy.

Brand names
Zicam Cold & Flu ReliefZicam Cold & Flu-Like Symptoms
Other names
Zicam Cold and Flu-Like Symptoms
02

Targets

ICAM1 (Intercellular Adhesion Molecule 1)

Beyond the preview

Go deeper on Zicam Cold & Flu Relief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zicam Cold & Flu Relief.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call